Evolving Role of Double and Triple Therapy With GLP-1 Receptor Agonists in Obesity and Cardiovascular Disease US$ 20.49 Min. order: 1 piece ★★★★★ 5.0 (291 reviews) Sold : Login>>
Emerging pharmacotherapies for obesity: A systematic review US$ 23.51 Min. order: 1 piece ★★★★★ 4.3 (280 reviews) Sold : Login>>
What Are the New Weight Loss Medications? US$ 21.13 Min. order: 1 piece ★★★★★ 4.4 (298 reviews) Sold : Login>>
Mazdutide vs Retatrutide: Which Weight Loss Injection Comes Out On Top? US$ 23.95 Min. order: 1 piece ★★★★★ 4.6 (249 reviews) Sold : Login>>
In Chinese adults with overweight or obesity, once-weekly #GLP/glucagon agonist mazdutide, at a dose of 4 mg or 6 mg for 32 US$ 24.77 Min. order: 1 piece ★★★★★ 4.0 (104 reviews) Sold : Login>>
Once-weekly mazdutide, a glucagon-like peptide-1 and glucagon receptor dual agonist, provided clinically relevant reduction in body weight in Chinese adults with obesity or overweight. Full GLORY-1 trial results: https://nej.md/4koUvaP US$ 26.65 Min. order: 1 piece ★★★★★ 4.3 (70 reviews) Sold : Login>>